RUNX1 and breast carcinoma: Given the recent discovery of RUNX1 and RUNX3 as tumor suppressors in the context of breast cancer and their known interaction with oncogene-YAP, we investigated whether YAP-RUNX interaction plays any role in molecular pathogenesis of breast cancer.